GO
Loading...

Update On FDA Panel: No Change On Stent Labels

FDA
CNBC.com
FDA

As we've been writing the past two days--CNBC pharmaceuticals reporter Mike Huckman has been reporting from Gaithersburg, Md., where the U.S. Food and Drug Administration convened a panel to decide the fate of drug-coated stents. Johnson & Johnson and Boston Scientific – the two major producers of stents – have been eagerly awaiting a decision. It appears to be in their favor.

Just recently the FDA chairman announced the panel didn’t have enough data to make a “sweeping recommendation to change the label on drug-coated stents.” The chair called the data “inconsistent,” “inadequate” and “uncertain.” That means doctors can continue using them.

There has been concern that the drug-coated stents (the other stents are metallic) can cause blood clots. Stents are medical devices implanted in patients to help prevent heart attacks. Some blood thinning medications have been prescribed for drug-coated stent patients.

Huckman will have an exclusive live interview with influential panelist Dr. Steven Nissen later on “Closing Bell.”

Contact Closing Bell

  • Showtimes

    United States
    Monday - Friday 3:00P ET
    Europe
    Monday - Saturday 21:00 CET
    Asia
    Tuesday - Saturday 03:00 SIN/HK
    Australia
    Tuesday - Saturday 05:00 SYD
    New Zealand
    Tuesday - Saturday 07:00 NZ
  • With almost 30 years experience in business television, Bill Griffeth is co-anchor of the 3 p.m. ET hour of CNBC's "Closing Bell."

  • Kelly Evans

    Kelly Evans is co-anchor of CNBC's "Closing Bell."

Subscribe